Savara Pharmaceuticals
SVRA
#6596
Rank
A$0.88 B
Marketcap
$5.13
Share price
-1.54%
Change (1 day)
-26.92%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -A$0.13 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$87.7 Million a decrease over its 2022 earnings that were of -A$61.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.13 Billion40.41%
2023 -A$87.7 Million43.38%
2022 -A$61.17 Million-11.31%
2021 -A$68.97 Million-13.3%
2020 -A$79.55 Million-36.53%
2019 -A$0.13 Billion13.76%
2018 -A$0.12 Billion105.54%
2017 -A$53.61 Million34.11%
2016 -A$39.97 Million-37.43%
2015 -A$63.88 Million38.81%
2014 -A$46.02 Million33.62%
2013 -A$34.44 Million38.49%
2012 -A$24.87 Million24.59%
2011 -A$19.97 Million-36.5%
2010 -A$31.44 Million-3.14%
2009 -A$32.46 Million-23.28%
2008 -A$42.3 Million8.52%
2007 -A$38.98 Million-34.14%
2006 -A$59.19 Million184.43%
2005 -A$20.81 Million90.75%
2004 -A$10.91 Million190.35%
2003 -A$3.76 Million11.64%
2002 -A$3.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$29.11 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.19 Billion 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA